Developmental and reproductive toxicity testing of vaccines

Journal of Pharmacological and Toxicological Methods

Volumn 65, Issue 2, 2012, Pages 58-63

  Barrow, Paul ^a  

^a SOLVO BIOTECHNOLOGY   (Hungary)

Author keywords

DART; Developmental toxicology; Reproductive toxicology; Teratology; Vaccines

Indexed keywords

DRUG PRESERVATIVE; IMMUNOGLOBULIN; IMMUNOLOGICAL ADJUVANT; MATERNAL ANTIBODY; STABILIZING AGENT; VACCINE;

ARTICLE; DEVELOPMENTAL TOXICITY; DRUG SURVEILLANCE PROGRAM; FEMALE FERTILITY; HUMAN; IMMUNOMODULATION; IMMUNOTOXICITY; JUVENILE TOXICITY; MALE FERTILITY; NONHUMAN; PASSIVE IMMUNIZATION; PRACTICE GUIDELINE; PREGNANCY; PREGNANCY OUTCOME; PRENATAL DRUG EXPOSURE; PRIMATE; PROGENY; RABBIT; REPRODUCTIVE TOXICITY; RISK ASSESSMENT; TOXICITY; TOXICITY TESTING; TOXICOLOGY; VACCINATION;

ABNORMALITIES, DRUG-INDUCED; ADJUVANTS, IMMUNOLOGIC; ADULT; ANIMALS; EMBRYO, MAMMALIAN; FEMALE; GUIDELINES AS TOPIC; HUMANS; IMMUNE SYSTEM; IMMUNITY, MATERNALLY-ACQUIRED; MACACA FASCICULARIS; MATERNAL EXPOSURE; MICE; MODELS, ANIMAL; PREGNANCY; RABBITS; RATS; REPRODUCTION; SPECIES SPECIFICITY; TERATOGENS; TOXICITY TESTS; VACCINES;

ANIMALIA; ORYCTOLAGUS CUNICULUS; PRIMATES; RODENTIA;

EID: 84859424810     PISSN: 10568719     EISSN: 1873488X     Source Type: Journal    
DOI: 10.1016/j.vascn.2011.12.001     Document Type: Article

References (39)

1. Allais L., Condevaux F., Fant P., Barrow P.C. Juvenile toxicity of cyclosporin in the rat. Reproductive Toxicology 2009, 28:230-238.
2. Baintner K. Transmission of antibodies from mother to young: Evolutionary strategies in a proteolytic environment. Veterinary Immunology and Immunopathology 2007, 117:153-161.
3. Barrow P.C., Ravel G. Immune assessments in developmental and juvenile toxicology: Practical considerations for the regulatory safety testing of pharmaceuticals. Regulatory Toxicology and Pharmacology 2005, 43:35-44.
4. Barrow P.C. Toxicology testing for products intended for pediatric populations. Nonclinical drug safety assessment: Practical considerations for successful registration 2007, 411-440. FDA News, Washington DC. W.K. Sietsema, R. Schwen (Eds.).
5. Barrow P.C. Reproductive toxicity testing for pharmaceuticals under ICH. Reproductive Toxicology 2009, 28:172-179.
6. Burns-Naas Leigh Ann, Hastings Kenneth L., Ladics Gregory S., Makris Susan L., Parker George A., Holsapple Michael P. What's so special about the developing immune system?. International Journal of Toxicology 2008, 27:223-254.
7. Chellman G.J., Bussiere J.L., Makori N., Martin P.L., Ooshima Y., Weinbauer G.F. Developmental and reproductive toxicology studies in nonhuman primates. Birth Defects Research. Part B, Developmental and Reproductive Toxicology 2009, 86:446-462.
8. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices. MMWR 48 (1999).
9. Centers for Disease Control and Prevention. Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 58 (2009) 1-8.
10. Daily Telegraph, (2010). Swine flu vaccine safety probed over link to rare sleep disorder. Published 27/08/10. Consulted 25/10/10. http://www.telegraph.co.uk/health/healthnews/7967815/Swine-flu-vaccine-safety-probed-over-link-to-rare-sleep-disorder.html.
11. Dietert R.R., DeWitt J. Developmental immunotoxicity (DIT): The why, when and how of DIT testing. Immunotoxicity testing: Methods and protocols 2010, 17-26. Humana Press, New York. R.R. Dietert (Ed.).
12. EMEA Note for guidance on preclinical pharmacological and toxicological testing of vaccines 1997, CPMP/SWP/465/95.
13. EMEA Guideline on the need for non-clinical testing in juvenile animals of pharmaceuticals for paediatric indications 2008, EMEA/CHMP/SWP/169215/2005.
14. FDA Draft guidance: Considerations for reproductive toxicity studies for preventive vaccines for infectious disease indications 2000.
15. FDA Guidance for industry: Considerations for developmental toxicity studies for preventive and therapeutic vaccines for infectious disease indications 2006.
16. FDA Guidance for industry: Nonclinical safety evaluation of pediatric drug products 2006.
17. Forster, this issue.
18. Gruber M.F. Maternal immunization: US FDA regulatory considerations. Vaccine 2003, 21:3487-3491.
19. Halliday R. Prenatal and postnatal transmission of passive immunity to young rats. Proceedings of the Royal Society of Edinburgh Section B: Biology 1955, 144:427-430.
20. Holladay S.D. Prenatal immunotoxicant exposure and postnatal autoimmune disease. Environmental Health Perspectives 1999, 107:687-691.
21. Holladay S.D., Sharova L.V., Punareewattana K., Hrubec T.C., Gogal R.M., Prater M.R., et al. Maternal immune stimulation in mice decreases fetal malformations caused by teratogens. International Immunopharmacology 2002, 2:325-332.
22. Hood R.D. Principles of developmental toxicology revisited. Developmental and reproductive toxicology: A practical approach 2006, 3-14. CRC Press, Boca Raton. R.D. Hood (Ed.).
23. House R.V., Selgrade M.J. A quarter-century of immunotoxicology: Looking back, looking forward. Toxicological Sciences 2010, 118:1-3.
24. ICH Harmonised Tripartite Guideline S5(R2). Detection of toxicity to reproduction for medicinal products & toxicity to male fertility 2005.
25. ICH Draft consensus guideline. Addendum to ICH S6: Preclinical safety evaluation of biotechnology-derived pharmaceuticals 2009.
26. Leibnitz R. Development of the human immune system. Developmental immunotoxicity 2005, 21-42. CRC Press, Boca Raton. S.D. Holladay (Ed.).
27. Offit P.A., Hackett C.J. Do vaccines cause allergic or autoimmune diseases?. Pediatrics 2003, 111:653-659.
28. OTIS (2010). Consulted 18/10/10. http://www.otispregnancy.org/vaccines-and-medications-in-pregnancy-surveillance-system-p135759.
29. Pentsuk N., van der Laan J.W. An interspecies comparison of placental antibody transfer: New insights into developmental toxicity testing of monoclonal antibodies. Birth Defects Research. Part B, Developmental and Reproductive Toxicology 2009, 86:328-344.
30. Plitnick L.M., Herzyk D.J. The T-dependent antibody response to Keyhole Limpet Hemocyanin in rodents. Immunotoxicity testing: Methods and protocols 2010, 159-172. Humana Press, New York. R.R. Dietert (Ed.).
31. Raghupathy R. Th1-type immunity is incompatible with successful pregnancy. Immunology Today 1997, 18:478-482.
32. Roitt I.M. Antifertility vaccines. Trends in Immunology 2002, 23:213-219.
33. Ryan M.A., Gumbs G.R., Conlin A.M., Sevick C.J., Jacobson I.G., Snell K.J., et al. Evaluation of preterm births and birth defects in liveborn infants of US military women who received smallpox vaccine. Birth Defects Research. Part A, Clinical and Molecular Teratology 2008, 533-539.
34. Schaefer C., Fritzsche J., Karbaum F., Meister R., Weber-Schoendorfer C. 2009 H1N1 vaccination in pregnancy - Experience of the European network of teratology information services (ENTIS). Reproductive Toxicology 2010, 30:220.
35. Stewart J. Developmental toxicity testing of monoclonal antibodies: An enhanced pre- and postnatal study design option. Reproductive Toxicology 2009, 28:220-225.
36. Thellin O., Heinen E. Pregnancy and the immune system: Between tolerance and rejection. Toxicology 2003, 185:179-184.
37. Verdier F., Barrow P.C., Bruge J. Reproductive toxicity testing of vaccines. Toxicology 2003, 185:213-219.
38. White K.L., Musgrove D.L., Brown R.D. The sheep erythrocyte T-dependent antibody response (TDAR). Immunotoxicity testing: Methods and protocols 2010, 173-184. Humana Press, New York. R.R. Dietert (Ed.).
39. Wise L.D., Buschmann J., Feuston M.H., Fisher J.E., Wah Hew K., Hoberman A.M., et al. Embryo-fetal developmental toxicity study design for pharmaceuticals. Birth Defects Research. Part B, Developmental and Reproductive Toxicology 2009, 86:418-428.